Page last updated: 2024-08-21

c.i. 42510 and Parkinson Disease

c.i. 42510 has been researched along with Parkinson Disease in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Britto, LR; de Souza, HD; Ferrazoli, EG; Nascimento, IC; Oliveira-Giacomelli, Á; Schwindt, TT; Ulrich, H	1
He, ZY; Luo, XG; Shang, H; Wang, XH; Xie, X	1
Appanna, VD; Appanna, VP; Auger, C; Castonguay, Z; Han, S; Thomas, SC	1

Reviews

1 review(s) available for c.i. 42510 and Parkinson Disease

Article	Year
The unravelling of metabolic dysfunctions linked to metal-associated diseases by blue native polyacrylamide gel electrophoresis. Analytical and bioanalytical chemistry, 2013, Volume: 405, Issue:6 Topics: Alzheimer Disease; Citric Acid Cycle; Electrophoresis, Gel, Two-Dimensional; Glycolysis; Humans; Metals, Heavy; Native Polyacrylamide Gel Electrophoresis; Obesity; Oxidative Stress; Oxidoreductases; Parkinson Disease; Protein Binding; Protein Conformation; Rosaniline Dyes; Sequence Analysis, Protein	2013

Article

Year

The unravelling of metabolic dysfunctions linked to metal-associated diseases by blue native polyacrylamide gel electrophoresis.

Analytical and bioanalytical chemistry, 2013, Volume: 405, Issue:6

Topics: Alzheimer Disease; Citric Acid Cycle; Electrophoresis, Gel, Two-Dimensional; Glycolysis; Humans; Metals, Heavy; Native Polyacrylamide Gel Electrophoresis; Obesity; Oxidative Stress; Oxidoreductases; Parkinson Disease; Protein Binding; Protein Conformation; Rosaniline Dyes; Sequence Analysis, Protein

2013

Other Studies

2 other study(ies) available for c.i. 42510 and Parkinson Disease

Article	Year
Brilliant Blue G, But Not Fenofibrate, Treatment Reverts Hemiparkinsonian Behavior and Restores Dopamine Levels in an Animal Model of Parkinson's Disease. Cell transplantation, 2017, 04-13, Volume: 26, Issue:4 Topics: Animals; Blotting, Western; Disease Models, Animal; Dopamine; Fenofibrate; Male; Parkinson Disease; Rats, Sprague-Dawley; Rosaniline Dyes; Substantia Nigra; Tyrosine 3-Monooxygenase	2017
Inhibiting purinergic P2X7 receptors with the antagonist brilliant blue G is neuroprotective in an intranigral lipopolysaccharide animal model of Parkinson's disease. Molecular medicine reports, 2017, Volume: 15, Issue:2 Topics: Animals; Disease Models, Animal; Dopaminergic Neurons; Imidazoles; Immunohistochemistry; Lipopolysaccharides; Male; Microscopy, Fluorescence; p38 Mitogen-Activated Protein Kinases; Parkinson Disease; Phosphorylation; Protective Agents; Purinergic P2X Receptor Antagonists; Pyridines; Rats; Rats, Sprague-Dawley; Rosaniline Dyes	2017

Article

Year

Brilliant Blue G, But Not Fenofibrate, Treatment Reverts Hemiparkinsonian Behavior and Restores Dopamine Levels in an Animal Model of Parkinson's Disease.

Cell transplantation, 2017, 04-13, Volume: 26, Issue:4

Topics: Animals; Blotting, Western; Disease Models, Animal; Dopamine; Fenofibrate; Male; Parkinson Disease; Rats, Sprague-Dawley; Rosaniline Dyes; Substantia Nigra; Tyrosine 3-Monooxygenase

2017

Inhibiting purinergic P2X7 receptors with the antagonist brilliant blue G is neuroprotective in an intranigral lipopolysaccharide animal model of Parkinson's disease.

Molecular medicine reports, 2017, Volume: 15, Issue:2

Topics: Animals; Disease Models, Animal; Dopaminergic Neurons; Imidazoles; Immunohistochemistry; Lipopolysaccharides; Male; Microscopy, Fluorescence; p38 Mitogen-Activated Protein Kinases; Parkinson Disease; Phosphorylation; Protective Agents; Purinergic P2X Receptor Antagonists; Pyridines; Rats; Rats, Sprague-Dawley; Rosaniline Dyes

2017